AZD1981 Midazolam CYP4503A Induction Study

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 31, 2009

Study Completion Date

April 30, 2009

Conditions

Healthy Male Volunteer

Interventions

DRUG

AZD1981

oral tablets during 14 consecutive days.

DRUG

Midazolam

Each subject will receive two single doses of 7.5 mg midazolam given as oral solution. The Midazolam dose will be given on Day 1 and on day 16.

Trial Locations (1)

Research Site, Uppsala